Some may benefit from twice-weekly dosing depending on: Dosing is individualized after medical evaluation
While these studies suggest potential benefits, they do not provide the level of evidence needed to confirm safety and efficacy in humans
DSS-induced colitis in mice elicited pronounced symptoms, including reduced locomotor activity, decreased consumption of food and water, dull and lifeless fur, signs of depression-like behavior, huddling behavior, perianal swelling and congestion, diarrhea, bloody stools, and substantial weight loss
How should healthcare providers approach the risk-benefit analysis for these treatments
Trained practitioners adjust depth dynamically based on tissue response during each session
Medical Disclaimer This blog post is intended for educational purposes only and does not constitute medical advice